The most common human ADAR1p150 Zα domain mutation P193A is well tolerated in mice
The most common human ADAR1p150 Zα domain mutation P193A is well tolerated in mice
Summary ADAR1 mediated A-to-I RNA editing is a self/non-self discrimination mechanism for cellular double stranded RNAs. ADAR mutations are one cause of Aicardi-Goutières Syndrome, an inherited paediatric encephalopathy, broadly classed as a “Type I interferonopathy”. The most common ADAR1 mutation is a proline 193 alanine (p.P193A) mutation, mapping to the ADAR1p150 isoform specific Zα domain. We report the development of an independent murine P195A knock-in mouse, homologous to the human P193A mutation. The Adar1P195A/P195Amice are largely normal and the mutation is well tolerated. Contrasting with previous reports when the P195A mutation was compounded with an ADAR1 null allele, the majority of mice have only a modest reduction in weaning weight and survived long-term. Severe runting and shortened survival of Adar1P195A/-animals are dependent on the parental genotype. The P195A mutation is well tolerated in vivo and the loss of MDA5 is sufficient to completely rescue the Adar1P195A/- mice.
Taylor Scott、Goradia Ankita、Heraud-Farlow Jacki、Walkley Carl R、Liang Zhen
St Vincent?ˉs Institute of Medical ResearchSt Vincent?ˉs Institute of Medical ResearchSt Vincent?ˉs Institute of Medical Research||Department of Medicine, Eastern Hill Precinct, Melbourne Medical School, University of MelbourneSt Vincent?ˉs Institute of Medical Research||Department of Medicine, Eastern Hill Precinct, Melbourne Medical School, University of MelbourneSt Vincent?ˉs Institute of Medical Research||Department of Medicine, Eastern Hill Precinct, Melbourne Medical School, University of Melbourne
基础医学生物科学研究方法、生物科学研究技术分子生物学
ADAR1A-to-I RNA editingP193A mutationZα domainMDA5dsRNAinnate immunity
Taylor Scott,Goradia Ankita,Heraud-Farlow Jacki,Walkley Carl R,Liang Zhen.The most common human ADAR1p150 Zα domain mutation P193A is well tolerated in mice[EB/OL].(2025-03-28)[2025-08-02].https://www.biorxiv.org/content/10.1101/2022.06.24.497437.点此复制
评论